18 March 2022 - Deborah Wilkes
- US CHPA honours Gary Downing
- Neuraxpharm recruits new country manager for Ireland
- US CRN announces hires and promotions
US CHPA honours Gary Downing
The US Consumer Healthcare Products Association (CHPA) has presented the Ivan D Combe Lifetime Achievement Award to Gary Downing.
The CHPA said Downing was a “consumer healthcare industry titan” who had “spent his entire career growing consumer healthcare companies of all shapes and sizes”.
Downing has been chief executive officer of Clarion Brands, Insight Pharmaceuticals, Lansinoh Laboratories and MedTech Products.
The CHPA said he had been an “active and dedicated” member for 38 years, including a period as chair of its Board of Directors from 2018 to 2020.
Scott Melville, the CHPA’s president and chief executive officer, highlighted Downing’s “incredible confidence”, “willingness to embrace risk and change” and “gratitude and humility”.
The CHPA says the annual award recognises the "outstanding work and contribution of individuals whose actions have created a lasting impact on the people and the affairs of the consumer healthcare sector, and directly improved self-care for consumers".
The award is named in honour of Ivan D Combe who served on the CHPA’s board from 1958 until 2000.
Neuraxpharm recruits country manager for Ireland
Neuraxpharm has recruited Tom Coogan as country manager for Ireland.
He replaces Craig Bowen who will focus on his position as general manager of the German company’s UK business.
Coogan joins Neuraxpharm from Grünenthal Pharma in Ireland where he has been managing director since 2004. He has also worked for Lundbeck, Organon and Pharmacia & Upjohn.
Coogan combined “a strong start-up mindset with nearly 30 years of experience in the pharmaceutical industry”, said Neuraxpharm.
The company pointed out that Coogan had set up Grünenthal’s business in Ireland and turned it into a leading player in the field of pain management and related diseases.
Neuraxpharm established its operations in Ireland in December 2020 through the acquisition of specialty pharmaceutical company Medinutrix, trading as Aribamed.
Neuraxpharm, which was known as NuPharm Group until October 2018, has been owned by private-equity firm Permira since 2020.
The German company’s goal is to be the “European leader in pharmaceutical products for treatment of the central nervous system (CNS)”.
Neuraxpharm has a direct presence in key European countries including Austria, the Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Poland, Portugal, Slovakia, Spain and the UK.
US CRN announces hires and promotions
The US Council for Responsible Nutrition (CRN) has hired two new people and promoted four existing members of staff.
Daniel Garza joins the trade association for the dietary supplement and functional food industry as a legislative and legal assistant. He previously worked for Invariant Government Relations.
Elise Hall joins the CRN as communications assistant, after working as a legislative intern in the office of Cathy McMorris Rodgers, the US representative for Washington’s 5th congressional district.
The first promotion involves Megan Olsen who is now senior vice president and general counsel. The CRN said she would continue to provide advice and legal counsel to members on litigation, legislation, regulatory compliance, advocacy and policy development, as well as advising staff on legal matters for the association.
Gretchen Powers has been promoted to vice president, marketing and member experience. The CRN said Powers would enhance connections between its communications functions and membership functions.
Haiuyen Nguyen has been promoted to vice president, regulatory and nutrition policy. The CRN said Nguyen would provide analysis and strategies for accomplishing its regulatory and public health and nutrition objectives, and would continue to develop its comments on supplement-related topics to federal agencies.
Finally, Tammie Betway has been promoted to office director and executive assistant to the chief executive officer.